Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
An uncommon first manifestation of multiple sclerosis: Tako-Tsubo cardiomyopathy.
Immune reconstitution and treatment response in multiple sclerosis following alemtuzumab.
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.
The signal intensity ratio of the optic nerve to ipsilateral frontal white matter is of value in the diagnosis of acute optic neuritis.
Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination.
Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in mice.
The impact of microglial activation on blood-brain barrier in brain diseases.
NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction.
Activation of endogenous neural stem cells for multiple sclerosis therapy.
Home or away? Choosing a setting for a falls-prevention program for people with multiple sclerosis.
Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
Ultrasound of inherited vs. acquired demyelinating polyneuropathies.
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
Acute neuronal apoptosis in a rat model of multiple sclerosis.
Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA).
A study of retinal parameters measured by optical coherence tomography in patients with multiple sclerosis.
Neurogenic Causes of Detrusor Underactivity.
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
Convergence yet Continued Complexity: A Systematic Review and Critique of Health Economic Models of Relapsing-Remitting Multiple Sclerosis in the United Kingdom.
Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis.
Multiparity in women with multiple sclerosis causes less long-term disability: Commentary.
Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence.
MicroRNA: Key regulators of oligodendrocyte development and pathobiology.
Pages
« first
‹ previous
…
689
690
691
692
693
694
695
696
697
…
next ›
last »